Cue Biopharma Inc (CUE)
1.705
+0.22
(+14.81%)
USD |
NASDAQ |
Nov 05, 16:00
1.705
0.00 (0.00%)
After-Hours: 16:14
Cue Biopharma Price: 1.705 for Nov. 5, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 04, 2024 | 1.51 | 1.64 | 1.45 | 1.485 | 425588.0 |
| Nov 01, 2024 | 1.65 | 1.69 | 1.425 | 1.52 | 579700.0 |
| Oct 31, 2024 | 1.72 | 1.740 | 1.480 | 1.61 | 670216.0 |
| Oct 30, 2024 | 1.71 | 1.899 | 1.69 | 1.75 | 592400.0 |
| Oct 29, 2024 | 1.75 | 1.95 | 1.60 | 1.69 | 781912.0 |
| Oct 28, 2024 | 1.46 | 1.86 | 1.46 | 1.78 | 861271.0 |
| Oct 25, 2024 | 1.54 | 1.63 | 1.31 | 1.48 | 885463.0 |
| Oct 24, 2024 | 1.63 | 1.68 | 1.50 | 1.56 | 475663.0 |
| Oct 23, 2024 | 1.60 | 1.61 | 1.50 | 1.57 | 370042.0 |
| Oct 22, 2024 | 1.68 | 1.68 | 1.50 | 1.60 | 696847.0 |
| Oct 21, 2024 | 1.33 | 1.899 | 1.281 | 1.68 | 5.537M |
| Oct 18, 2024 | 1.15 | 1.23 | 1.10 | 1.21 | 320744.0 |
| Oct 17, 2024 | 1.07 | 1.14 | 1.040 | 1.11 | 312467.0 |
| Oct 16, 2024 | 1.08 | 1.145 | 0.9852 | 1.07 | 679276.0 |
| Oct 15, 2024 | 1.23 | 1.28 | 1.11 | 1.12 | 317472.0 |
| Oct 14, 2024 | 1.20 | 1.241 | 1.170 | 1.21 | 191007.0 |
| Oct 11, 2024 | 1.31 | 1.38 | 1.181 | 1.23 | 464658.0 |
| Oct 10, 2024 | 1.16 | 1.46 | 1.120 | 1.33 | 1.054M |
| Oct 09, 2024 | 1.19 | 1.240 | 0.71 | 1.205 | 1.538M |
| Oct 08, 2024 | 1.38 | 1.40 | 1.11 | 1.23 | 1.102M |
| Oct 07, 2024 | 1.19 | 1.45 | 1.15 | 1.385 | 2.325M |
| Oct 04, 2024 | 0.86 | 1.23 | 0.801 | 1.16 | 6.035M |
| Oct 03, 2024 | 0.7214 | 0.8799 | 0.7011 | 0.8192 | 569582.0 |
| Oct 02, 2024 | 0.7081 | 0.7418 | 0.69 | 0.7334 | 172606.0 |
| Oct 01, 2024 | 0.77 | 0.7796 | 0.681 | 0.7197 | 337815.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.4541
Minimum
Sep 26 2024
30.73
Maximum
Jun 02 2020
8.323
Average
4.45
Median
May 15 2023
Price Benchmarks
| Biomarin Pharmaceutical Inc | 66.06 |
| Arbutus Biopharma Corp | 3.955 |
| GlycoMimetics Inc | 0.3898 |
| FibroGen Inc | 0.304 |
| Cidara Therapeutics Inc | 13.43 |
Price Related Metrics
| PS Ratio | 9.927 |
| Price to Book Value | 4.748 |
| Earnings Yield | -57.48% |
| Market Cap | 102.65M |